Evaluating the use of recombinant human activated protein C in adult severe sepsis: results of the surviving sepsis campaign. Critical care medicine, May 2012, Vol. 40(5), p.1417-1426.
Casserly, B., et al.
http://journals.lww.com/ccmjournal/Abstract/2012/05000/Evaluating_the_use_of_recombinant_human_activated.4.aspx
The Surviving Sepsis Campaign developed guidelines for the administration of recombinant human activated protein C in adult severe sepsis. However, it is not clear how these impacted clinical practice or patient outcome.
No comments:
Post a Comment